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Abstract
Alcohol abuse is a major public health problem worldwide. Understanding the molecular mechanisms that control regular
drinking may help to reduce hazards of alcohol consumption. While immunological mechanisms have been related to
alcohol drinking, most studies reported changes in immune function that are secondary to alcohol use. In this report, we
analyse how the gene “TRAF family member-associated NF-κB activator” (TANK) affects alcohol drinking behavior. Based on
our recent discovery in a large GWAS dataset that suggested an association of TANK, SNP rs197273, with alcohol drinking,
we report that SNP rs197273 in TANK is associated both with gene expression (P = 1.16 × 10−19) and regional methylation
(P = 5.90 × 10−25). A tank knock out mouse model suggests a role of TANK in alcohol drinking, anxiety-related behavior, as
well as alcohol exposure induced activation of insular cortex NF-κB. Functional and structural neuroimaging studies among
up to 1896 adolescents reveal that TANK is involved in the control of brain activity in areas of aversive interoceptive
processing, including the insular cortex, but not in areas related to reinforcement, reward processing or impulsiveness. Our
ﬁndings suggest that the cortical neuroimmune regulator TANK is associated with enhanced aversive emotional processing
that better protects from the establishment of alcohol drinking behavior.
Key words: alcohol, anxiety, drinking, insular cortex, NF-κB, TANK
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Introduction
Alcohol is a toxic substance that is regularly consumed virtu-
ally worldwide with the risk of developing an alcohol addiction.
Non-addictive consumption is integrated in many cultural
activities (Heath 2000; Müller and Schumann 2011). However,
even non-addicted regular alcohol drinking is causing major
public health problems (WHO 2014) with the burden of alcohol
associated diseases being largely related to the level of alcohol
consumption in the general population (Rehm et al. 2009). It
has long been recognized that small shifts in the mean of a
continuously distributed behavior such as alcohol drinking can
have major public health beneﬁts. For example, a shift from
heavy to moderate drinking could have beneﬁcial effects on
cardiovascular disease risk (Rose 1981). Understanding the
mechanisms regulating regular alcohol consumption could,
therefore, lead to public health beneﬁts from reducing regular
alcohol consumption.
Alcohol drinking is a heritable behavior, with heritability
estimates ranging from 24% to 75% (Heath et al. 1991). While
the genetic mechanisms of alcohol addiction are emerging
(Treutlein et al. 2009), very few mechanisms have been identi-
ﬁed so far for non-addicted alcohol consumption (Stacey et al.
2012) or alcohol instrumentalization (Müller and Kornhuber
2017; Müller et al. 2017; Ahmed et al. 2018). While immunologi-
cal mechanisms have been related to alcohol drinking, most
studies reported changes in immune function that are second-
ary to alcohol use. In a recent genome-wide association study
(GWAS) meta-analysis of alcohol intake, we identiﬁed a sugges-
tive signal for the TRAF family member-associated NF-κB acti-
vator (TANK) gene SNP rs197273 (A/G) with the minor A allele
associated with reduced drinking (discovery sample: P = 1.02 ×
10−8) (Schumann et al. 2016). This effect of the minor A allele
was slightly higher in men (beta = −0.017, P = 4.4 × 10−5) than
women (beta = −0.01, P = 0.002). This ﬁnding supported a GWAS
study on dietary macronutrient intake that also identiﬁed a sig-
nal for TANK SNP rs197273 (Chu et al. 2013), suggesting a poten-
tial overlap in the genetic regulation of macronutrient choice
and alcohol consumption (Talukdar et al. 2016).
TANK is localized on chromosome 2q24 and encodes a scaf-
folding protein involved in immune receptor signaling. TANK
was identiﬁed as an intracellular protein that interacts with
tumor necrosis factor receptors (TNFR)-associated factors (TRAF)
(Cheng and Baltimore 1996). It links receptors of the IL-1R/Toll
and TNF receptor family to signaling cascades, leading to the
activation of NF-κB and mitogen-activated protein kinases
(ERK1/2) (Nomura et al. 2000). TANK plays an important role in
Toll-like receptor signaling (Wajant et al. 2001), innate immunity
(Kawai and Akira 2007), bone turnover (Maruyama et al. 2012),
and autoimmune nephritis (Kawagoe et al. 2009). In neuronal
tissue, it is involved in sensory neuron repair, survival and neur-
ite growth (Salerno et al. 2013) and degeneration (Pottier et al.
2015). Although it is also expressed in the brain, its role in
behavioral control is unknown. However, recent studies have
suggested Toll-like receptors and innate immune signaling in
the brain contribute to alcohol drinking (Crews et al. 2017). Here
we asked what functional consequences the rs197273 TANK
polymorphism has for the regulation of alcohol drinking and
addiction related behavioral dimensions (Schumann et al. 2014)
and how these effects are mediated in the brain. For this pur-
pose, we investigated the effects of TANK rs197273 on gene
expression and its mediation by DNA methylation in humans. In
order to estimate the impact of this SNP on brain functions
related to drug abuse, we evaluated how rs197273 affects fMRI
brain processing during reward learning, impulsivity and emo-
tional responses in humans. In order to conﬁrm this role of
TANK in alcohol consumption and emotional behavior experi-
mentally, we tested tank knock out (KO) mice. They were also
used to identify a potential mechanism of how TANK might act
in a key cortical brain structure involved in emotional responses
as identiﬁed in the human fMRI study.
Material and Methods
Framingham Heart Study population description
To investigate if rs197273 in TANK has an effect on gene expres-
sion, we investigated 2 independent cohorts for TANK RNA
expression. In 1971, the offspring and their spouses (Offspring
cohort, N = 5124) of the Original cohort participants were
recruited and have been examined approximately every 4 years
(except 8 years between the ﬁrst and the second examination).
From 2002 to 2005, the adult children (Third Generation cohort,
N = 4095) of the Offspring cohort participants were recruited
and were examined for the ﬁrst time (Splansky et al. 2007). The
examination 2 of the Third Generation was begun in May of
2008 and was completed in February 2011.
In Framingham Heart Study, the information of alcohol con-
sumption was collected by asking questions to the participants
on drinking of beer, wine and spirits (80 proof) in the past year
at each examination cycle. A drink was deﬁned as having 12 oz
of beer (in bottle, can, or glass, which was equivalent to ~14 g of
alcohol), 5 oz of wine (~15 g of alcohol), or 1.5 oz of liquor (~14 g
of alcohol). The continuous g/day was derived from numbers of
drinks consumed. “Current non-drinkers” were subjects with
no alcohol consumption (i.e., g/day = 0). “Current light drin-
kers” were subjects who consumed 0 < g/day ≤ 28 in men and 0
< g/day ≤ 14 in women. “Current at risk-drinkers” were subjects
who consumed 28<g/day < 42 in men and 14 < g/day < 28 in
women. “Current heavy drinkers” were subjects who consumed
≥42 g/day in men and ≥28 g/day in women.
Gene Expression Proﬁling in the Framingham Heart
Study
The blood samples of a total of 5626 participants from the
Offspring (N = 2446) at examination 8 and the Third Generation
(N = 3180) at examination 2 were collected for gene expression
proﬁling (Huan et al. 2015). Fasting peripheral whole-blood sam-
ples (2.5mL) were collected in PAXgene™ tubes (PreAnalytiX,
Hombrechtikon, Switzerland). RNA expression proﬁling was con-
ducted using the Affymetrix Human Exon Array ST 1.0
(Affymetrix, Inc., Santa Clara, CA) for samples that passed the
RNA quality control. The expression values for ~18 000 tran-
scripts were obtained from the total 1.2 million core probe sets.
Quality control procedures for transcripts were described previ-
ously (Joehanes et al. 2013). All data used herein are available
online in dbGaP (http://www.ncbi.nlm.nih.gov/gap; accession
number: phs000007).
Gene Expression Proﬁling in the IMAGEN Study
The IMAGEN consortium (www.imagen-europe.com), “Reinfor-
cement behaviour in normal brain function and psychopathol-
ogy” has recruited n = 2090 participants from 4 European
countries assessed at baseline at an age of 14 years, with cur-
rent follow-up assessments (Schumann et al. 2010). In the
IMAGEN study, total RNA of 592 individuals was extracted from
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whole-blood cells using the PAXgene Blood RNA Kit (QIAGEN
Inc., Valencia, CA). Following quality control of the total RNA
extracted, labeled complementary RNA (cRNA) was generated
using the Illumina® TotalPrep™ RNA Ampliﬁcation kit (Applied
Biosystems/Ambion, Austin, TX). cRNA was puriﬁed and quan-
tiﬁed using a Qubit® 2.0 Fluorometer (Invitrogen, Paisly, UK).
The size distributions of cRNA was determined through
Bioanalyzer (Agilent Technologies, Santa Clara, CA) using the
Eukaryotic mRNA Assay with smear analysis. Gene expression
proﬁling was performed using Illumina HumanHT-12 v4
Expression BeadChips (Illumina Inc., San Diego, CA). Expression
data was normalized using the loess method.
DNA Methylation Quantiﬁcation in the Framingham
Heart Study
To investigate if rs197273 in TANK has an effect on DNA meth-
ylation, we quantiﬁed DNA methylation in participants from
the Framingham Heart Study. The DNA samples were obtained
from the peripheral whole blood of 2846 Offspring who pro-
vided consent for genetic study at examination 8 using the
Puregene DNA extraction kit (Qiagen, Venlo, Netherlands).
Bisulﬁte conversion of genomic DNA was performed with the
EZ DNA Methylation kit (Zymo Research, Irvine, CA). DNA
methylation was quantiﬁed after whole genome ampliﬁcation,
fragmentation, array hybridization, and single-base pair exten-
sion. The measured DNA methylation was processed using the
DASEN methodology implemented in the wateRmelon R pack-
age (6) (version 3.0.2, http://www.bioconductor.org/packages/
release/bioc/html/wateRmelon.html). The methylated and
unmethylated ﬂuorescent intensities (M and U) and technical
variations were adjusted. Then, quantile normalization of the
M and U values were performed with consideration of 2 types
of probe technologies. Beta values were then derived as the
ratio of methylated probe intensity to the overall intensity. For
quality control purposes, we compared genotypes of the 65
SNPs obtained in methylation and in previous genotyping
efforts. We excluded samples with a probe missing rate >1%
(n = 45), poor SNP matching to the 65 SNP control probe loca-
tions (n = 79), and outliers by multi-dimensional scaling techni-
ques (n = 73). At the probe level, we excluded those with
missing rate >20% at P < 0.01 (n = 466 from laboratory 1 and n =
366 from Laboratory 2), as well as probes previously identiﬁed
to map to multiple locations or have an underlying SNP (minor
allele frequency >5% in European ancestry (EUR) 1000 genomes
project data) at the CpG site or ≤10 bp of the single-base exten-
sion (n = 42 251). After quality control, 2651 (522 in S1 and 2129
in S2) samples with ~440 000 CpG probes were used for subse-
quent analyses.
Genotyping and Imputation in the Framingham Heart
Study
Genotyping was performed using The Affymetrix 500 K map-
ping array and the Affymetrix 50 K gene-focused MIP array after
quality control procedures. MACH (version 1.0.15) was used to
impute all autosomal SNPs genotyped in the 1000 Genomes
Project using the publicly available reference set (Sanger ver-
sion). The single-nucleotide polymorphisms (SNPs) that were
within 100 kb of the signiﬁcant CpGs were selected (minor allele
frequency >5% and imputation quality score (r2 > 0.5) from
1000 G imputation data).
cis-Expression Quantitative Trait Loci Analysis in the
Framingham Heart Study
To investigate if rs197273 in TANK has potential biological func-
tions, we performed cis-eQTL analysis. The SNP in each gene
was used as the independent variable in association analysis
with the transcript of TANK that was measured using whole-
blood samples in the Framingham Heart Study (n = 5236). Age,
sex, BMI, batch effects, and blood cell differentials were
included as covariates in the association analysis. Linear mixed
model was used to account for familial correlation in associa-
tion analysis.
cis-Methylation Quantitative Trait Loci Analysis in the
Framingham Heart Study
To investigate if the signiﬁcant SNP is also mQTLs for DNA
methylation sites of TANK, we performed association analysis
using the SNPs as the independent variables and the top princi-
pal components (PC) of methylations as the outcome variables
in the Framingham Heart Study (n = 2427). Twenty CpG sites
are in or ±5 kb of the TANK gene. To account for multiple test-
ing, we ﬁrst performed PCA using the methylation site in or
±10 kb of a gene. 3 top PC that can explain at least 5% of the
variance in all CpGs of each gene were retained. The top PC
were used as the outcome variables in association analysis
with the SNPs adjusting for age, sex, BMI, batch effects, and cell
differentials. A linear mixed model was used to account for
familial structure (Schumann et al. 2016).
Association of TANK Gene Expression with Alcohol
Consumption in the Framingham Heart Study
We performed an association analysis between TANK gene
expression level and categorical alcohol consumption. The
mean TANK gene expression level was compared between cur-
rent heavy alcohol drinkers/moderate alcohol drinkers/light
drinkers versus current non-drinkers, adjusting for age, sex,
BMI, and family structure.
cis-Methylation and Gene Expression in the NIMH Brain
Tissue Collection
Probes mapping all different gene variants were selected when
analysing mQTL in the brain in the NIMH Brain Tissue
Collection (Colantuoni et al. 2011). Raw gene expression 2-color
microarray (Illumina Human 49 K Oligo array (HEEBO-7 set))
intensity data from postmortem dorsolateral prefrontal cortex
(DLPFC) were downloaded (available at GSE30272) and, among
them, data from individuals free from psychiatric and/or neu-
rologic diagnoses and substance abuse according to DSM-IV
were loess-normalized as described previously (Colantuoni
et al. 2011). Processed and normalized DNA methylation data
generated by the Illumina HumanMethylation450 microarray
on samples that had both DNA methylation and expression
data were also collected as described before (Jaffe et al. 2016).
Expression probes were re-annotated to the hg19 genome on
these samples by using the Gemma tool (Zoubarev et al. 2012)
as described previously (Jaffe et al. 2016). For methylation–
expression associations, we ﬁrst performed PCA using the
methylation site in or ±10 kb of a gene, and the PC explaining
>5% of the variance were used in association analysis with the
corresponding gene expression by linear regression model.
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Animals
Mice and respective controls were tested for their alcohol con-
sumption. Tank was isolated from genomic DNA extracted from
embryonic stem cells (GSI-I) by PCR. The targeting vector was
constructed by replacement of a 2.0-kb fragment encoding the
tank open reading frame with a neomycin-resistance gene cas-
sette; the gene encoding herpes simplex virus thymidine kinase
driven by the promoter of the gene encoding phosphoglycerate
kinase was inserted into the genomic fragment to facilitate neg-
ative selection. After transfection of the targeting vector into
embryonic stem cells, colonies doubly resistant to the aminogly-
coside G418 and ganciclovir were selected, screened by PCR and
further conﬁrmed by Southern blot analysis. Homologous
recombinants were microinjected into blastocysts from C57BL/6
female mice, and heterozygous F1 progenies were inter-crossed
to obtain tank–/– (tank KO) mice. Tank KO mice on the 129 Sv ×
C57BL/6 background and their controls were used (Kawagoe
et al. 2009). Littermate mice were individually housed for alcohol
drinking tests or group housed for emotional behavior tests and
immunohistochemistry, provided with food and water ad libi-
tum, and kept on a 12:12 h light: dark cycle (lights on at 1.00 pm).
Room temperature was maintained between 19 °C and 22 °C at a
humidity of 55% (±10%). tank KO mice develop at an age of 6
month severe glomerulonephritis with renal failure as the most
likely reason for an enhanced mortality after that age (Kawagoe
et al. 2009). In our study, we tested mice only at younger age (<3
month) and did not observe abnormal spontaneous behavior or
enhanced lethality. All experiments were carried out in accor-
dance with the Animal Protection Law of the Federal Republic of
Germany and the European Communities Council 2010 Directive
(2010/63/EU). They were all approved by the local authority
“Regierung von Mittelfranken”.
Alcohol Drinking and Withdrawal Effects
Alcohol drinking was tested in naïve male mutant and wild-type
(WT) control mice (8-weeks-old) using a 2-bottle free-choice
drinking paradigm. In this test, male mice were used since we
observed the stronger TANK association with alcohol drinking
in human males. Each cage was equipped with 2 bottles con-
stantly available, one of which contained tap water the other
bottle contained alcohol in various concentrations. After an
acclimatization period to establish a drinking baseline, animals
received alcohol at increasing concentrations of 2, 4, 8, 12, and
16 vol.%. Mice were exposed to each concentration of alcohol
for 4 days. Bottles were changed and weighed daily. The con-
sumed amount of alcohol relative to body weight and the pref-
erence versus water were measured (Stacey et al. 2012; Easton
et al. 2013).
Alcohol Deprivation Effect
Thereafter, ethanol concentration was maintained at 16 vol.%
and animals were allowed to drink for 2 weeks. In order to
measure the ethanol deprivation effect, baseline consumption
of 16 vol.% ethanol was measured. Ethanol was removed for 3
weeks (both bottles containing tap water) before it was re-
introduced for 4 days. This procedure was repeated one more
time. Bottles were weighed daily and their positions were chan-
ged every other day. The consumed amount of ethanol relative
to body weight and the preference versus water were measured
and corrected for ﬂuid loss (Stacey et al. 2012; Easton et al.
2013).
Taste Preference Test
Alcohol experienced animals were used for this test. Sucrose
(0.5% and 5%) and quinine (2 and 20mg/dL) preference was mea-
sured in a 2-bottle free-choice test versus water. Each dose was
offered for 3 days with the position of the bottles being changed
and weighed daily (Stacey et al. 2012; Easton et al. 2013). A new
batch of mice was tested for saccharine preference in a 2-bottle
free-choice test versus water. Saccharin was offered for 3 days,
respectively, at concentration of 0.5% and 1%.
Blood Alcohol Determination
Naïve mice received an i.p. alcohol injection (3.5 g/kg) and 20-μL
blood samples were obtained from the submandibular vein 1, 2,
and 3 h after alcohol injection. The blood samples were sub-
jected to enzymatic alcohol determination using the alcohol
dehydrogenase method as described elsewhere (Zheng et al.
2016; Müller et al. 2017).
Emotional Behavior
Naïve male and female tank KO and WT mice were tested for
their emotional behavior. Open Field: Each mouse was placed in
a square gray acrylic arena (50 × 50 cm), facing an outer wall,
for 20min (parameters were measured per 5-min blocks and
summarized) and allowed to freely explore the arena. White
light of 25 lx was evenly distributed across the arena during
testing. Video recordings were taken and analysed using
Biobserve Viewer III (Biobserve GmbH, Germany). A virtual
square of equal distance from the periphery (36 × 36 cm) was
deﬁned as the “central zone” in order to determine the number
of entries, and time (s) spent in the central zone. Distance
moved in the outer and central zones (cm), number of entries
and time spent in the central zone were registered (Easton
et al. 2011; Mielenz et al. 2018). Elevated Plus Maze: The elevated
plus maze was constructed from gray opaque acrylic with gray
lining on the ﬂoor, each arm measuring 30 × 5 cm and the cen-
tral platform 5 × 5 cm. One set of arms, opposing one another,
were enclosed completely by a wall of opaque acrylic, 15-cm
high, while the other set was open. The maze was elevated
50 cm from the ground. Each mouse was placed on the central
platform, facing towards a closed arm, and allowed to freely
explore the maze for 5min. Videomot2 tracking software (TSE
Systems GmbH, Germany) was used to record locomotor activ-
ity during the test (distance moved in the open and closed
arms), and the number of entries into the closed and open
arms and time spent in them, recorded from the center of the
animal position (Easton et al. 2011; Mielenz et al. 2018). Novelty-
suppressed feeding: Animals were deprived from food for 24 h
before novelty-suppressed feeding test. After deprivation each
mouse was put in the corner of a square gray acrylic arena (50 ×
50 × 50 cm), facing an outer wall. White light of 25 lx was evenly
distributed across the arena during testing. A piece of food was
placed in the center of the arena. Video recordings were taken
and analysed using Videomot2. The time (s) before a mouse
began eating after the fasting period (24-h) and the distance
moved before eating were registered (Easton et al. 2011; Mielenz
et al. 2018). Since we did not observe sex effects on these para-
meters, data were collapsed for analysis.
Immunohistochemistry
Naïve male and female tank KO and WT mice were treated i.g.
with ethanol (5 g/kg, i.g., 25% ethanol, w/v), or with equal
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volume water (control), daily for 10 days. Mice were then
injected intraperitoneally with saline (control) or lipopolysac-
charide (LPS; 3mg/kg, i.p.; strain O111:B4; Calbiochem, San
Diego, CA, in saline) 24 h after the last dose of ethanol. One
hour after LPS injection, mice were anesthetized with sodium
pentobarbital and transcardially perfused with phosphate buff-
ered saline (PBS) followed by 4% (w/v) paraformaldehyde in
PBS. Coronal sections (40 μm) were cut on a sliding microtome
(MICROM HM450, ThermoScientiﬁc, Austin, TX), and sections
were sequentially collected into 24-well plates and stored at
−20°C in a cryoprotectant solution (30% glycol/30% ethylene
glycol in PBS) for immunohistochemistry. Free ﬂoating anterior
insula (AI) sections were processed for immunostaining as pre-
viously described (Qin and Crews 2012). The sections were
washed in PBS and antigen retrieval was performed by incuba-
tion in Citra solution (BioGenex, San Ramon, CA) for 1 h at 70°C.
Following incubation in blocking solution, slides were pro-
cessed in primary antibody p-NF-κB p65 (1:200; p-NFκB p65 (Ser
276) (SC-101749) rabbit polyclonal IgG, Santa Cruz
Biotechnology, Inc., Dallas, TX) overnight at 4°C, and the sec-
ondary antibody, biotinylated goat anti-rabbit IgG (H + L; Vector
Laboratories Inc., Burlingame, CA) was used at a 1:200 dilution
for 1 h. The immune labeling was visualized using nickel-
enhanced 3,3′-diaminobenzidine (DAB). Negative control for
non-speciﬁc binding was conducted on separate sections
employing the above-mentioned procedures with the exception
that the primary antibody was omitted. For the assessment of
p-NF-κB p65 positive immunoreactivity (p-NF-κB p65+IR), a
modiﬁed method was used to quantify cells within regions of
interest. p-NF-κB p65 +IR was assessed in 3 randomly selected
region of AI per hemisphere, for a total of 6 AI regions per ani-
mal. BioQuant Nova Advanced Image Analysis (R&M Biometrics
Inc., Nashville, TN) was used for image capture and quantiﬁca-
tion. The number of p-NF-κB p65 + IR cells was counted within
the AI regions. Since we did not observe sex effects on these
parameters, data were collapsed for analysis.
Neuroimaging Analyses
Data were acquired from 1896 14-year-old adolescents from the
IMAGEN project. The recruitment procedures employed in the
IMAGEN project and demographic information have been
described previously (Schumann et al. 2010; 2016). Data from
facial emotion processing task (FT) was available from 1456
participants, data from the successful inhibition trials of the
stop signal task (SST) was available from 1286 participants and
data from reward anticipation task (MID) was available from
1327 participants.
Standard Operating Procedures
The standard operating procedures for the IMAGEN project are
available at http://www.imagen-europe.com/en/Publications_
and_SOP.php and contain details on ethics, recruitment, neuro-
psychological tests, instructions for the SST (French, English,
and German), and for blood collection and storage.
Emotional Faces Processing Task
Emotion processing was investigated using the “faces task”
(FT). Participants were exposed to a sequence of stimuli which
consisted of short (2–5 s) black-and-white video clips showing
male and female faces with varying facial expressions. Stimuli
showed human faces which started with the expression of a
neutral expression and then either turned angry or displayed a
neutral movement without a particular emotional content (for
example, twitching the nose). Stimuli were arranged in 18 s
blocks, each block including 4–7 video clips depicting faces of
the same emotion (either angry or neutral). Altogether, there
were 5 blocks of neutral faces and 5 blocks containing angry
faces. In between 2 blocks of face clips, an 18 s non-biological
control video clip was presented. The control stimuli consisted
of expanding and contracting black-and-white concentric cir-
cles of various contrasts, roughly matching the contrast and
motion characteristics of the faces clips.
Stop Signal Task
Participants also performed an event-related SST designed to
study neural responses to successful and unsuccessful inhibi-
tory control. The task was composed of Go trials and Stop trials.
During Go trials (83%; 480 trials) participants were presented
with arrows pointing either to the left or to the right. During
these trials, subjects were instructed to make a button response
with their left or right index ﬁnger corresponding to the direc-
tion of the arrow. In the unpredictable Stop trials (17%; 80
trials), the arrows pointing left or right were followed (on aver-
age 300ms later) by arrows pointing upwards; participants
were instructed to inhibit their motor responses during these
trials. A tracking algorithm changes the time interval between
Go signal and Stop signal onsets according to each subject’s
performance on previous trials (average percentage of inhibi-
tion over previous Stop trials, recalculated after each Stop trial),
resulting in 50% successful, and 50% unsuccessful inhibition
trials. The inter-trial interval was 1800ms. The tracking algo-
rithm of the task ensured that subjects were successful on 50%
of Stop trials and worked at the edge of their own inhibitory
capacity.
Monetary Incentive Delay Task
The participants performed a modiﬁed version of the Monetary
Incentive Delay (MID) task to study neural responses to reward
anticipation and reward feedback18. This event-related task
consisted of 66 10-s trials. In each particular trial, participants
were presented with one of 3 cue shapes (cue, 250ms) denoting
whether a target (a white square) would subsequently appear
on the left or right side of the screen and whether 0, 2, or 10
points could be won in that particular trial. After a variable
delay (4000–4500ms) of ﬁxation on a white crosshair, partici-
pants were instructed to respond by pressing a button with
their left or right index ﬁnger as soon as the target appeared.
Feedback on whether and how many points were won during
the trial was presented for 1450ms after the response. Using a
tracking algorithm, task difﬁculty (i.e., target duration varied
between 100 and 300ms) was individually adjusted such that
each participant successfully responded on ~66% of trials.
Participants had ﬁrst completed a practice session outside the
scanner (for ~5min), during which they were instructed that
for each 5 points won they would receive one food snack in the
form of small chocolate candies. The current study used the
contrast ‘anticipation high win versus no win’. Only successful
trials were included in analysis.
Neuroimaging Acquisition and Pre-processing
Full details of the MRI acquisition protocols and quality checks
have been described previously, including an extensive period
of standardization across MRI scanners (Schumann et al. 2010).
Effect of MRI site was controlled by adding it as a nuisance
covariate in all statistical analyses. MRI data were processed
using SPM8 (Statistical Parametric Mapping, http://www.ﬁl.ion.
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ucl.ac.uk/spm/). Time series data were corrected for slice tim-
ing, then for movement, non-linearly warped onto MNI space
using a custom EPI template, and Gaussian-smoothed at 5-mm
full-width half maximum. Estimated movement (3 translations,
3 rotations, 3 translations shifted one volume acquisition
before, and 3 translations shifted one volume acquisition later)
parameters were added as nuisance variables. Each fMRI time
series underwent automatic spike detection and any artifactual
time points were regressed out of each subject’s data. For the FT,
BOLD responses during “angry faces” versus BOLD responses dur-
ing “control” stimuli were contrasted. For the SST, BOLD
responses during “successful stop” versus BOLD responses during
“successful go” were contrasted. For the MID, BOLD responses
during “high win” versus BOLD responses during “no win” were
contrasted. For each contrast, individual contrast images were
then taken to group-level analyses.
Genotyping and Association Analysis
DNA puriﬁcation and genotyping of the IMAGEN sample were
performed by the Centre National de Génotypage in Paris. DNA
was puriﬁed from whole-blood samples (~10mL) preserved in
BD Vacutainer EDTA tubes (Becton, Dickinson and Company,
Oxford, UK) using the Gentra Puregene Blood Kit (Qiagen,
Manchester, UK) according to the manufacturer’s instructions.
A total of 705 and 1382 individuals were genotyped with the
Illumina (Little Chesterford, UK) Human610-Quad Beadchip and
Illumina Human660-Quad Beadchip, respectively. For each gen-
otyping platform, the following quality control was performed
separately. Single-nucleotide polymorphisms (SNPs) with call
rates <95%, minor allele frequency <5%, deviation from the
Hardy–Weinberg equilibrium (P ≤ 10−3) and non-autosomal
SNPs were excluded from the analyses. Individuals with exces-
sive missing genotypes (failure rate >5%) were also excluded.
Population homogeneity was examined with the Structure soft-
ware using HapMap populations as reference groups.
Individuals with divergent ancestry (from Utah residents with
ancestry from northern and western Europe) were excluded.
Identity-by-state clustering and multi-dimensional scaling
were used to estimate cryptic relatedness for each pair of indi-
viduals using the PLINK software and closely related
individuals were eliminated from the subsequent analysis. We
applied PCA to remove remaining outliers, deﬁned as indivi-
duals located at more than 4 SD of the mean PCA scores on one
of the ﬁrst 20 dimensions. Finally, the integrated genotypes
from both Illumina Human610-Quad BeadChip and Human660-
Quad BeadChip were combined and platform-speciﬁc SNPs
were removed. After the quality control measures, we obtained
a total of 466 125 SNPs in 1834 individuals. The imputation was
done by minimac, and the reference is EUR 1000 Genomes
(Phase 1 version 3; November 2010).
For association analysis between genetic risk for alcohol
consumption and brain activation, we ﬁrst computed a gene
score based on local SNPs. We assigned to the TANK gene in
the genome a set of SNPs that lie within 100-kb upstream and
50-kb downstream of the gene’s most extreme transcript
boundaries. We thus captured signals from potential causal
variants affecting regulatory elements as well as variants
affecting amino acid sequence (non-synonymous variants). We
then carried out LD clumping on these SNPs with r2 = 0.02.
Each gene is then assigned a score as a summation of their
SNPs (Supplementary Table S4), weighted by effect sizes esti-
mated from GWAS of alcohol drinking.
Statistical Analysis
All data are expressed as means ± SEM. Statistical analysis
between the 2 groups was performed by unpaired 2-tailed
Student’s t-test using Excel or GraphPad Prism (GraphPad
Software, Inc.). For multiple comparisons, analysis of variance
(ANOVA) with pre-planned Bonferroni-corrected LSD tests or
post hoc Tukey was done when appropriate, using SPSS.
Results
Association of rs197273 with TANK Gene Expression in
Humans
We investigated whether SNPs rs197273 is associated with gene
expression of TANK in humans. We ﬁrst tested the relation of
genotype and gene expression in peripheral blood of 5236 partici-
pants of the Framingham study (Splansky et al. 2007). For demo-
graphic characteristics of the sample, see: Table 1. We found an
association of the minor A-allele of rs197273 with TANK gene
expression (P = 1.16 × 10−19) (Fig. 1A–B; Supplementary Table S1A).
We replicated this association among 592 14-year old participants
of the IMAGEN study (Schumann et al. 2010) (P = 0.032) (Fig. 1C;
Supplementary Table S2A), a group that has not yet started drink-
ing substantial amounts of alcohol, suggesting that the allele spe-
ciﬁc effect on gene expression is not secondary to long term
alcohol abuse. In silico analyses of data from the discovery sample
(Schumann et al., 2016) revealed an inverse association of the A-
allele of rs197273 with gene expression in liver tissue (P = 0.015),
and direct association in the brain (thalamus) (P = 0.015), but no
association in adipose tissue (Supplementary Table S3). For demo-
graphic characteristics of this sample, see: Table 2. These ﬁndings
suggest an association of the TANK SNP rs197273 with TANK gene
expression at adolescent as well as at adult age.
rs197273 Effects on Gene Expression are Related to DNA
Methylation
Since rs197273 is localized in close proximity to several CpG
sites, we investigated whether the effect of this SNP on gene
expression is mediated by DNA methylation. We analysed in
Table 1 Demographics for gene expression and methylation in
peripheral blood in the Framingham Heart Study
Phenotypes/
covariates
Offspring Cohort
(examination cycle
8:2005-2008)
Third Generation
Cohort (examination
cycle 2:2008-2011)
Gene Expression
Analysis
n = 2222 n = 3014
Female (%) 1221 (54.95) 1603 (53.10)
Age (years), mean
(SD)
66.41 (8.95) 46.88 (8.79)
BMI (kg/m2), mean
(SD)
28.04 (5.87) 28.31 (5.53)
Methylation Analysis n = 2062
Female (%) 1140 (55.28)
Age (years), mean
(SD)
66.30 (8.96)
BMI (kg/m2), mean
(SD)
28.35 (5.31)
BMI: Body mass index.
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the Framingham offspring study (n = 2427) methylation data
from CpG sites ±5 kb of the gene locus using the Illumina 450k
chip (Table 1). A principal component analysis (PCA) of the 20
probes in this region revealed 3 principal components (PC)
explaining more than 5% of total variance in methylation. The
second principal component (PC2), which maps the shelves of 2
CpG islands adjacent to TANK 3′UTR accounts for 14% of the
explained variance, and is signiﬁcantly associated with
rs197273 (P = 5.90 × 10−25) (Fig. 1B; Supplementary Table S1B).
The PC2 is also associated with TANK gene expression in
peripheral blood (P = 1.4 × 10−61) and in the DLPFC (P =
5.0×10−19) (Fig. 1B; Supplementary Table S1C, S1D). The effect of
rs197273 on gene expression in peripheral blood is mediated by
PC2 (Supplementary Table S1E).
TANK Gene Expression and Alcohol Consumption
About 25.2% of Framingham Heart Study participants were current
non-drinkers, 57.2% were current light-drinkers, 11.0% were cur-
rent at-risk drinkers, and 6.6% of individuals were heavy drinkers.
The mean level of TANK gene expression is higher in current hea-
vy drinkers compared with current non-drinkers. However, this
association was borderline signiﬁcant (beta/SE = 0.029/0.016, P =
0.07). The mean level of TANK gene expression did not show
different in current light drinkers (P = 0.70) or in current mild drin-
kers (P = 0.89) compared with current non-drinkers.
TANK Affects Alcohol Drinking in Mice
Next, we investigated alcohol drinking in tank KOmice. We mea-
sured ethanol intake and preference using a 2-bottle free-choice
alcohol drinking test. Tank KO mice showed signiﬁcantly lower
alcohol consumption (F1,105 = 28.2771, P < 0.0001) than WT con-
trols at the 8 vol.% (P < 0.01), 12 vol.% (P < 0.05), and 16 vol.%
alcohol (P < 0.01) (Fig. 2A). Also, the preference of alcohol versus
water was signiﬁcantly reduced (F1,105 = 15.9561, P < 0.0002) at 8
vol.% (P < 0.031) and 12 vol.% (P < 0.039) alcohol (Fig. 2B).
However, total ﬂuid intake, indicative of general drinking activity
was not affected by the lack of TANK (P > 0.05; Fig. 1C).
Thereafter, animals were left undisturbed with water and 16
vol.% alcohol available for 14 days, during which the reduced con-
sumption was maintained in the tank KO mice (F1,21 = 17.4186, P <
0.0005). When animals were repeatedly withdrawn from alcohol
drinking for 3 weeks each time, and then reinstated, they main-
tained a genotype effect (F1,8 = 18.6691, P < 0.0003) and showed an
alcohol deprivation effect (ADE) which became evident by a tem-
porarily restricted increase of consumption (Day: F8,168 = 8.1122, P
< 0.0001; genotype × day interaction: F8,168 = 2.2879, P < 0.0237).
Results showed a signiﬁcant increase in alcohol consumption in
the WT mice on the ﬁrst day after second withdrawal versus the
day before withdrawal (P < 0.0001). Also, the tank KO mice devel-
oped an ADE, which was signiﬁcant after the second withdrawal
(P < 0.0072). However, this effect was signiﬁcantly reduced com-
pared with WT mice (P < 0.0001) (Fig. 2D). Also, alcohol preference
was signiﬁcantly attenuated in the tank KO mice during with-
drawal testing (genotype: F1,8 = 12.4997, P < 0.0019; Day: F8,168 =
2.2905, P < 0.0236; interaction: P > 0.05), but did not reach signiﬁ-
cance versus baseline at single day level (P > 0.05; Fig. 2E). Total
ﬂuid consumption during withdrawal was not affected by the
genotype (P > 0.05), but was enhanced by the alcohol deprivation
in both groups to a comparable degree (Day: F8,168 = 10.8922, P <
0.0001; interaction: P > 0.05, Fig. 2F). In the WT mice, this was
Figure 1. Schematic diagrams of the TANK gene structure. (a) Possible mechanisms linking the TANK single-nucleotide polymorphism rs197273 to TANK gene expres-
sion through DNA methylation in the (b) Framingham and (c) in the IMAGEN study.
Table 2 Demographics for gene expression in peripheral blood in
the IMAGEN study
N %
Female 980 51.7
Right handed 1683 88.8
Mean SD
Age 14.6 0.45
Verbal IQ 110.7 14.85 14.9
Performance IQ 107.6 14.8
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signiﬁcant on Day 1 of the second reinstatement (P < 0.0001). In
the tank KO mice, this was signiﬁcant on Day 1 (P < 0.0144) and
Day 4 (P < 0.0064) of the ﬁrst reinstatement, as well as on Days 1
and 2 (P < 0.0001) and Day 4 (P < 0.0232) of the second reinstate-
ment. These ﬁndings suggest reduced alcohol consumption and
preference, as well as an attenuated ADE in mice lacking tank.
Given that total ﬂuid consumption was comparable between
genotypes, this effect may not be the consequence of reduced or
impaired locomotor activity in the tank KO mice.
We found that the avoidance of a bitter tasting quinine solu-
tion was not altered in tank KO mice compared with WT mice
(P > 0.05; Fig. 3A). However, tank KO mice showed a signiﬁcantly
lower preference for sweet tasting sucrose solution comparted
with WT mice with 0.5% (P < 0.002) and 5% sucrose (P < 0.006).
We tested animals for their preference for saccharin solution,
which is sweet tasting, but devoid of carbohydrate calories, and
found also here a lower preference in tank KO mice (F1,70 =
4.453; P = 0.0384) which was most evident for the 1% concentra-
tion (P < 0.034) (Fig. 3B). The tank KO had no effect on alcohol
bioavailability in mice (P > 0.05; Fig. 3C). Altogether, these ﬁnd-
ings suggest that TANK contributes to sweetness preference
independent of the nutritional content of the food.
No Role of rs197273 in Reward Processing and
Impulsivity
We investigated single SNPs and gene scores of TANK associa-
tion with brain activity indexed by blood oxygenation-level
dependent (BOLD) signal, during reinforcement-related neuroim-
aging tasks relevant to alcohol drinking in up to 1456 14-year-old
adolescents of the IMAGEN study (Schumann et al. 2010;
Table 2). We calculated a polygenic risk score as a summation of
the effects of the common variants, weighted by effect sizes
from our quantitative GWAS data on alcohol intake (Huan et al.
2015; Schumann et al. 2016) (Supplementary Table S4). The MID
task was used as a measure of reward processing. For each vox-
el, we calculated the test statistic for the association between
SNP or gene score and activation (Euesden et al. 2015). We used
a signiﬁcance threshold of P ≤ 0.001 after a conservative family
wise error correction. We did not ﬁnd a relationship between
TANK and altered reward processing (P > 0.05).
Differences in alcohol consumption may also be accounted
for by altered impulsivity. Brain activation with the orbitofron-
tal cortex as region of interested was measured during the SST
in the same adolescents. Also for the SST, neither whole-brain
analysis nor region of interest analyses exceeded the signiﬁ-
cance threshold. Moreover, no associations were found with
intracranial brain volume or gray matter thickness (P > 0.05).
These data suggest that TANK SNP rs197273 does not affect the
incentive properties of a rewarding stimulus or impulsivity.
rs197273 Predicts Cortical Response to Emotional
Stimuli
Humans and animals may consume alcohol in order to cope
with anxiety and stress (Müller and Schumann 2011). We inves-
tigated single SNPs and the gene scores of TANK for associations
with brain activity during the viewing of angry faces—designed
to assess processing of negative emotions that are related to
emotional stress, and involving a social component in up to
1456 14-year-old adolescents of the IMAGEN study (Schumann
et al. 2010; Table 2). We used a signiﬁcance threshold of P ≤
Ethanol solution (v/v)
2% 4% 8% 12%16%
E
ta
no
l c
on
su
m
pt
io
n 
(g
/k
g/
d)
0
2
4
6
8
10 TANK +/+
TANK –/–
**
* **
Ethanol solution (v/v)
2% 4% 8% 12%16%
P
re
fe
re
nc
e 
ra
tio
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8 TANK +/+
TANK –/–
* *
TANK +/+
TANK –/–
Ethanol solution (v/v)
2% 4% 8% 12%16%T
ot
al
 fl
ui
d 
co
ns
um
pt
io
n 
(m
l/k
g/
d)
0
50
100
150
200
250
300
TANK +/+
TANK –/–
Drinking days
Bl R1 R2 R3 R4 R5 R6 R7 R8
A
lc
oh
ol
 c
on
su
m
pt
io
n 
(g
/k
g/
d)
 
0
2
4
6
8
10
12
14
16
**
***
Bl R1 R2 R3 R4 R5 R6 R7 R8
Drinking days
P
re
fe
re
nc
e 
ra
tio
 
0.0
0.1
0.2
0.3
0.4
0.5
0.6 TANK +/+
TANK –/–
Bl R1 R2 R3 R4 R5 R6 R7 R8
Drinking days
T
ot
al
 fl
ui
d 
co
ns
um
pt
io
n 
(m
l/k
g/
d)
 
0
50
100
150
200
250
300 TANK +/+
TANK –/–
***
* **
***
****
(a) (b) (c)
(d) (e) (f)
Figure 2. TANK is required to establish normal alcohol drinking in mice. tank KO (n = 11) and wild-type (WT; n = 12) mice were tested in a free-choice 2-bottle drinking
paradigm for their alcohol consumption. (a) Amount of alcohol consumed at different concentrations of the drinking ﬂuid. (b) Preference of alcohol versus water.
(c) Total ﬂuid consumption during testing (pre-planned Bonferroni-corrected LSD test; *P < 0.05, **P < 0.01; vs. WT). (d) Consumption of 16 vol.% alcohol after 2 weeks
of drinking and alcohol deprivation effect (ADE) in tank KO (n = 11) and WT (n = 12) mice. After continuous drinking, animals were withdrawn from alcohol for 2 times
3 weeks (dotted lines) and reinstated (R) for 4 days, respectively, (e) alcohol preference and (f) total ﬂuid consumption during ADE (pre-planned Bonferroni-corrected
LSD test; *P < 0.05, **P < 0.01; ***P < 0.001 vs. baseline (Bl)).
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0.001 after a conservative family wise error correction. In this
analysis, the angry FT exceeded this signiﬁcance threshold
(Fig. 4; Table 3). The “protective” A-allele of TANK rs197273 was
associated with a stronger BOLD response in the right inferior
temporal gyrus (P = 0.001, cluster size = 229mm3, peak T value =
4.44) and with a stronger response in a cluster involving the left
middle temporal gyrus and the left inferior occipital gyrus (P =
9.15 × 10−4, cluster size = 232mm3, peak T value = 3.71; Fig. 4A
and 4C; Table 3). For the TANK gene score, we found the stron-
gest association of the brain response to angry faces (vs. control
stimulus) in a cluster in the left insula and the inferior frontal
gyrus (P = 1.1×10−5, cluster size = 375mm3, peak T value = 3.92).
For an allele speciﬁc analysis, see: Supplementary information;
Supplementary Figures S1–S3. An additional cluster was
detected in the right insula (P = 5.2 × 10−4, cluster size = 249mm3,
peak T value = 4.63; Fig. 4B and 4D; Table 3; Supplementary Figs
S4–S6), a region involved in interoceptive processing and drug
craving (Contreras et al. 2007). These ﬁndings suggest that TANK
is associated with cortical emotion processing, in particular in
the insular cortex.
TANK Affects Anxiety in Mice
In order to explore how TANK affects emotional behavior, we
used naïve tank KO mice and tested them in behavioral para-
digms measuring anxiety and depression (Easton et al. 2011;
Mielenz et al. 2018). In the elevated plus maze, tank KO mice
showed higher levels of anxiety-related behaviors compared
with WT. This was evident by less time (P < 0.0284) and loco-
motion (P < 0.0223) spent on the open arms of the maze, and
more time spent in the closed arms (P = 0.01; Fig. 5A–B). This
was conﬁrmed by an analysis of relative open arm time (t =
2.098, P < 0.0482), which suggests that the anxiogenic effect is
not locomotor dependent (Fig. 5C).
The open ﬁeld (OF) test further supported more anxiety-
related behavior in tank KO mice in a novel environment. This
was evident by a signiﬁcant reduction in the time (P < 0.0394)
and number of entries (P < 0.0271) to the center of the OF in the
ﬁrst 5min of testing (Fig. 5E–F). The locomotion in the center
(F1,21 = 23.9442; P < 0.0001) as well as total locomotion (F1,21 =
45.9935; P < 0.0001) was lower in tank KO mice during the whole
test period, suggesting a general reduction in locomotor activity
in a novel environment (Fig. 5G–H). There was no difference in
depression-related behavior in the novelty-suppressed feeding
test (P > 0.05; Fig. 5D). Altogether, these data suggest that a lack
of TANK enhances anxiety-related behavior towards novel
stimuli.
TANK Regulates Alcohol-Induced NF-κB in the Insular
Cortex
TANK signaling is linked to activation, i.e., expression, of the
transcription factor NF-κB that increases neuroimmune signal-
ing, which can regulate drinking and anxiety by activation of
TANK-binding kinase 1 (TBK1) (Crews et al. 2017). NF-κB is acti-
vated by alcohol in the brain (Zou and Crews 2010) inducing
innate immune responses, which can further promote alcohol
drinking in rodents and humans (Edenberg et al. 2008). Such an
increase can be driven by a pro-inﬂammatory event, e.g., LPS,
or by alcohol itself (Blednov et al. 2011). The insula was found
to be a critical brain region for the control of aversion-resistant
alcohol consumption (Seif et al. 2013). We identiﬁed the insular
cortex as a brain area whose activity differs during emotional
processing dependent upon the speciﬁc TANK alleles. Here, we
asked whether alcohol induces NF-κB activation in the insular
cortex by TANK activation. We treated tank KO mice sub-
chronically with i.g. alcohol or water. In addition, animals
received an injection with LPS or vehicle. Using immunohis-
tochemistry, we found that alcohol and LPS enhanced p-NF-κB
immunoreactivity in the AI of the mice (alcohol vs. control: P <
0.01 (WT), P < 0.05 (tank KO); LPS vs. control: P < 0.01 (WT and
KO)). This effect was potentiated when both treatments were
combined (P < 0.01). All effects on p-NF-κB were signiﬁcantly
attenuated in tank KO mice (P < 0.01; Fig. 6). These ﬁndings sug-
gest that TANK contributes to chronic alcohol- and LPS-
induced NF-κB activation in the insula.
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Figure 3. TANK controls preference for sweet taste in a 2-bottle free-choice par-
adigm in tank KO (n = 11) and wild-type (WT; n = 12) mice. (a) Sucrose (sweet)
preference and quinine (bitter) avoidance test in a free-choice 2-bottle drinking
paradigm indicates no difference between tank KO (n = 11) and WT mice (n =
12) in the avoidance of bitter tasting quinine, but a reduced preference for
sucrose (pre-planned Bonferroni-corrected LSD test; ##P < 0.01). (b) A saccharine
preference test in a free-choice 2-bottle drinking paradigm indicates a reduced
preference for sweet tasting, but caloric neutral saccharin in naïve tank KO
mice (n = 12) versus WT (n = 12) (pre-planned Bonferroni-corrected LSD test;
#P < 0.05). (c) TANK has no effect on alcohol bioavailability in mice. Blood alcohol
concentration in tank KO (n = 10) and WT mice (n = 10) after alcohol injection
(3.5 g/kg, i.p.). Over the 3-h tested, there was no difference in alcohol bioavailabil-
ity between genotypes (P > 0.05).
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Discussion
This study aimed to identify a mechanism which may explain
how TANK exerts its control on alcohol consumption. In contrast
to a number of previously described genetic mechanisms that all
affect functions of the reward system in the brain and alcohol
effects thereupon (Stacey et al., 2012; Easton et al., 2013;
Schumann et al. 2011, 2016), here we describe a genetic mecha-
nisms that acts via neuroimmune modulation of cortical emo-
tional processing. The TANK gene SNP rs197273 was identiﬁed as
a possible locus for alcohol drinking and macronutrient choice in
large GWAS meta-analyzes in humans (Chu et al. 2013;
Schumann et al. 2016). Here, we report that the minor A-allele of
SNP rs197273 is associated with reduced TANK gene expression in
humans. We identiﬁed an enhanced CpG methylation of TANK as
a potential mediating mechanism in minor A-allele carriers. The
minor A-allele of SNP rs197273, which leads to reduced expression
of TANK, is associated with lower alcohol consumption.
Experimental tests in young adult mice conﬁrmed that a lack of
TANK leads to a reduced alcohol consumption and attenuates
withdrawal-induced escalation of consumption. Adolescent
humans of the IMAGEN sample with the rs197273 TANK A-allele
drink less alcohol (Schumann et al., 2016) and have more negative
affective responses in the insular cortex (this study). Together,
this may suggest a role of TANK particularly in the acquisition
and early phase of alcohol drinking. Our ﬁndings in mice support
a role for TANK in regulating alcohol activation of neuroimmune
signaling in the insula, an area that is crucial for emotional
responses. Blunted alcohol-induced cortical neuroimmune activa-
tion in this region may limit alcohol consumption in individuals
with reduced TANK expression.
Based on a previous association of the minor A-allele of
TANK SNP rs197273 with alcohol consumption in humans
(Schumann et al., 2016), we sought to explore mechanisms of
this association. Here, we report in 2 independent samples that
Figure 4. Association of whole-brain activity during social emotional processing with the tank gene. Brain regions associated with (a/c) TANK rs197273 and (b/d) TANK
gene score during angry faces task. Red and blue colors represent a positive association and a negative association, respectively.
Table 3Whole-brain association analysis with SNPs and polygenetic risk scores (PRS) for TANK in “angry face” processing
Peak T value’s MNI
co-ordinates
Peak T value Cluster Size FWE-corrected
P-value
Positive association with TANK rs197273
Right Inferior Temporal gyrus 21,−91,4 4.44 229 0.001
Left Middle Temporal gyrus, Left Inferior Occipital gyrus −42,−61,1 3.71 232 9.15 × 10−4
Negative association with TANK rs197273
Right Paracentral gyrus, Right Middle cingulum gyrus 12,−40,52 4.18 194 0.0034
Negative association with TANK PRS
Right Insula 42,−1,−17 4.63 249 5.20 × 10−4
Right Paracentral gyrus, Right Middle cingulum gyrus 12,−40,52 4.51 124 0.048
Left Insula, Left Inferior frontal gyrus −36,−4,−2 3.92 375 1.11 × 10−5
Right Parahppocampus, Right Fusiform gyrus, Right Cerebelum 24,−43,−5 3.86 163 0.011
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the minor A-allele of SNP rs197273 is associated with a reduc-
tion in TANK gene expression. This may be explained by the
increase in TANK (PC2) methylation that was found to be asso-
ciated with the minor A-allele of SNP rs197273 as well as with
gene expression.
The human ﬁndings have been associative by nature, and
only suggest, but do not prove a causal involvement. This can
only be achieved when TANK function is experimentally
manipulated. In a translational approach, we tested the role of
TANK in alcohol drinking in mice. Herein, we conﬁrmed the
human phenotype, in that reduced TANK availability leads to a
reduced consumption and preference of alcohol in mice. Also,
the effects of repeated withdrawal on alcohol drinking were
attenuated in mice lacking TANK. Importantly, we did not
observe general reduction in drinking behavior, i.e., in total
ﬂuid consumption, which suggests that locomotor activity
required for drinking is basically preserved. These data may
conﬁrm the human phenotype and suggest a role for TANK in
alcohol drinking.
Mice lacking TANK showed a reduced preference for a usually
preferred sucrose solution. Since TANK was implicated in macro-
nutrient choice, in particular for carbohydrates (Chu et al. 2013),
we asked whether the caloric content or the sweet taste might be
responsible for the change in taste preference. This test showed
also a reduced preference for the sweet tasting, but caloric neu-
tral saccharin solution. These ﬁndings may conﬁrm a role of
TANK in carbohydrate choice, which is mainly guided by its
hedonic taste properties, rather than by the caloric content. Since
changes in sweet taste perception may affect mainly alcohol con-
sumption at low concentrations of alcohol, the effects on taste
perception may not account for the observed attenuation in
alcohol consumption, which is most striking at high alcohol
concentrations.
We did not ﬁnd an effect of rs197273 on reward processing
in the brain reward pathway during the MID task. However, the
“protective” A-allele of TANK rs197273 was associated with
stronger activation of the right inferior temporal gyrus and
with stronger activation of a cluster involving the left middle
temporal gyrus and the left inferior occipital gyrus. These brain
regions have been linked to psychological and physiological
stress reactions, to alcohol craving, and alcohol-addiction
related behaviors (Cooper et al. 1995; Seif et al. 2013; Sutherland
et al. 2013). Using a task where negative emotions are pro-
cessed, we discovered that the TANK gene score was associated
with activation of a cluster in the insula. The insula is a key
region for dynamic interoceptive processing that integrates
somatosensory information with emotional salience of aversive
as well as pleasant stimuli (Craig 2009; Hassanpour et al. 2018).
It is also involved in risk prediction and risk adjustment during
decision making (Bossaerts 2010). During risky decision making,
insula activation was associated with better harm avoidance in
healthy individuals (Paulus et al. 2003). It was shown that
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Figure 5. TANK controls anxiety-related behavior in mice. Tank KO mice display more anxiety-related behavior in a novel environment than wild-type (WT) mice.
Enhanced anxiety in the elevated plus maze test (EPM) by tank KO (n = 12) vs. WT (n = 11) mice shown by (a) reduced time spent and (b) less distance moved on open
arms (P < 0.05) and (c) less relative time in open arms. (d) No effect on depression-related behavior in the novelty-suppressed feeding test in tank KO mice. (e) In the
open ﬁeld (OF) test, tank KO mice (n = 12) spend less time in the anxiogenic center of the maze than WT mice (n = 11). (f) The number of OF center entries is reduced
in tank KO mice. Locomotor activity of tank KO mice is reduced in (g) the center of the maze, but also (h) when total locomotion is considered (pre-planned
Bonferroni-corrected LSD test; #P < 0.05; $P < 0.001 vs. WT).
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problematic substance use is associated with reduced responsive-
ness of the insula to non-drug related aversive cues (Paulus and
Stewart 2014; Stewart et al. 2014). Pleasant cues, however, may be
processed with higher sensitivity in substance abusers (Stewart,
May et al. 2015). Alcohol use disorder and neuroticism were asso-
ciated with a lower cortical thickness of the insula in humans
(Zhao et al. 2017). In non-addicts, alcohol consumption is con-
trolled by the aversive side effects of the consumption, which can
also be cue-conditioned (Riley 2011). Aversive cues and memories
can suppress alcohol consumption in non-addicts (Limpens et al.
2014; Labots et al. 2018). In that, a strong processing of aversive
interoceptive signals may counteract risky behaviors such as
drug abuse (Paulus et al., 2009). A loss of responses to aversive
cues and of conditioned suppression of drug consumption are
considered as a classical indicators for alcohol addiction in
humans (Kim et al. 2014) and animal models (Vendruscolo et al.
2012; Seif et al. 2013). It was suggested that an attenuated proces-
sing of aversive interoceptive states, such as induced by aversive
memories of drug side effects, may put an individual at higher risk
for drug dependence. Our ﬁndings may thus be interpreted in a
way that the TANK polymorphism enhances responsiveness to
aversive interoceptive cues in the insula, and, by that way, pro-
vides resilience to the establishment of risky alcohol consumption.
After the human ﬁndings suggested a role of TANK in aver-
sive emotional processing, we sought to verify a role in a trans-
lational approach. Using 2 tests of (state) anxiety, we found
that a lack of TANK leads to enhanced levels of anxiety-related
behaviors in both, the EPM as well as the OF test. A test of
depression-like behavior, however, did not suggest a role of
TANK. In both, the EPM and OF, but not in the NSF test, tank KO
mice showed less locomotion that WT controls. This effect
could, however, be separated from the anxiogenic action.
Altogether, these tests may suggest a role of TANK in anxiety
related, but not in depression-related behavior.
TANK is involved in inﬂammatory processes (Kawagoe et al.
2009). An inﬂammation, induced by LPS in healthy volunteers
was shown to enhance AI cortex responses and cortical con-
nectivity after an acute aversive pain stimulus (Karshikoff et al.
2016; Lekander et al. 2016). In a molecular analysis in mice, we
found that TANK is required for the alcohol- and/or
inﬂammation-induced increase of NF-κB in the insular cortex,
which can drive escalation of alcohol consumption (Edenberg
et al. 2008). These ﬁndings suggest a unique inﬂuence of TANK
on insular cortex processing. TANK is associated with alcohol
drinking, in a way which limits the risk of alcohol-induced neu-
roimmune activation and its driving of drinking escalation. The
present ﬁndings might implicate that a stronger cortical activa-
tion during negative emotions, possibly related to negative
interospective memories of consumption episodes (Müller
2013), may facilitate a proper risk assessment for alcohol con-
sumption and, thus, limit alcohol consumption in non-
addictive drinking.
This study has some limitations that need to be considered
when estimating the importance of TANK for alcohol abuse
and emotion. First, the strong association in the discovery sam-
ple reached only a nominal signiﬁcance in an independent rep-
lication sample (replication: P = 0.04; discovery and replication
combined: P = 7.4 × 10−8) (Schumann et al. 2016). Thus, TANK
effects may be limited to distinct populations. Second, the
association refers to general alcohol consumption that is dis-
tinct from addiction. It should be noted that genetic and brain
mechanisms of controlled drug use are largely distinct from
those mediating the transition to addiction (Müller and
Homberg 2015). In this study, we have used an animal model
with a constitutive KO of tank to translate human associations
into an experimental approach in animals. While this model
translates the human situation of a live long reduction in
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TANK function in a whole body mouse KO, it does not allow
extracting the most effective brain area(s) responsible for local
TANK action in mice. It may also slightly over-estimate the effect
size that the human SNP may possibly have. Furthermore, the
alcohol drinking study measured only male mice and conﬁrmed
the human association in males. While a somewhat weaker asso-
ciation between TANK and alcohol consumption was also
observed in human females (Schumann et al. 2016), this still has
to be tested in female mice separately. No such limitation applies
to emotional behavior and neuroimmune responses, were we did
not observe sex effects of TANK.
In summary, our ﬁndings suggest that the cortical neuroim-
mune regulator TANK, for which a naturally occurring muta-
tion was associated with alcohol drinking in humans, is
involved in cortical aversive emotion processing and related
control of alcohol drinking behavior.
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Supplementary material is available at Cerebral Cortex online.
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